FLS
60
5
ADI
54
5
NVDA
56
5
NWS
58
2
AFL
32
2
KMX
42
-12
UNP
36
3
LB
64
18
ETR
68
5
HES
57
3
BSX
64
3
V
58
2
VMC
33
3
NDAQ
50
2
THC
41
-2
AMAT
42
9
BXP
38
4
ACN
45
-2
NRG
39
12
MNST
52
-2
FLS
60
5
ADI
54
5
NVDA
56
5
NWS
58
2
AFL
32
2
KMX
42
-12
UNP
36
3
LB
64
18
ETR
68
5
HES
57
3
BSX
64
3
V
58
2
VMC
33
3
NDAQ
50
2
THC
41
-2
AMAT
42
9
BXP
38
4
ACN
45
-2
NRG
39
12
MNST
52
-2
Financhill
Back

Mineralys Therapeutics Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
38

MLYS
Mineralys Therapeutics

Last Price:
$12.74
Seasonality Move:
51.51%

7 Day Trial

ALL ACCESS PASS

$ 7

Elon Musk Dreams, Mode Mobile Delivers

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Mineralys Therapeutics Stock Forecast

  • Is Mineralys Therapeutics Stock Undervalued?
    The current Mineralys Therapeutics [MLYS] share price is $12.75. The Score for MLYS is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • MLYS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Mineralys Therapeutics Stock Go Up Next Year?

Data Unavailable

Mineralys Therapeutics Stock Rating

Data Unavailable

Mineralys Therapeutics Stock Price History

Is MLYS stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MLYS is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
mineralystx.com

52-Week Data

52-Week High:
16.91
52-Week Low:
7.95

Prediction Charts

Market Cap:
634.6M
Price in USD:
12.75
Volume:
158.2K
Beta:
1.45

Technical Analysis

SMA50:
12.90
SMA100:
12.55
SMA200:
12.60
52-Wk Change:
49.12%

Stock Predictions

  • Is Mineralys Therapeutics stock public?
    Yes, Mineralys Therapeutics is a publicly traded company.
  • What is the Mineralys Therapeutics stock quote today?
    The Mineralys Therapeutics stock price is 12.75 USD today.
  • How to buy Mineralys Therapeutics stock online?
    You can buy Mineralys Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-13 12.04 11.90 12.06 11.61
Dec-16 12.13 12.16 12.30 11.74
Dec-17 12.04 12.35 12.44 11.97
Dec-18 12.44 11.67 12.57 11.44
Dec-19 11.75 11.83 12.16 11.19
Dec-20 11.73 12.33 12.50 11.55
Dec-23 12.20 12.06 12.34 11.73
Dec-24 12.31 12.80 12.81 11.99
Dec-26 12.59 12.87 13.00 12.05
Dec-27 12.81 12.82 13.43 12.50
Dec-30 12.76 12.52 12.91 12.03
Dec-31 12.55 12.31 12.69 12.04
Jan-2 12.33 12.25 12.66 12.00
Jan-3 12.33 12.75 12.99 12.16

Mineralys Therapeutics Earnings

Data Unavailable

Mineralys Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.16 per share, and an increase next year of $0.34 per share.

* Mineralys Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.